A placebo-controlled, double-blind study of fluoxetine in severe alcohol dependence: Adjunctive pharmacotherapy during and after inpatient treatment

Alcoholism: Clinical and Experimental Research

Volumn 20, Issue 4, 1996, Pages 780-784

  Kabel, David I ^a,b   Petty, Frederick ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

Alcoholism; Fluoxetine; Selective Serotonin Reuptake Inhibitors

Indexed keywords

ALCOHOL; COCAINE; FLUOXETINE;

ADULT; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DEPENDENCE; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SCORING SYSTEM; SEROTONINERGIC TRANSMISSION; SOCIAL SUPPORT; TREATMENT FAILURE;

ADULT; AFTERCARE; ALCOHOLISM; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; FLUOXETINE; HUMANS; MALE; MIDDLE AGED; PATIENT ADMISSION; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0029948988     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1996.tb01686.x     Document Type: Article

References (32)

1. Liskow BI, Goodwin DW: Pharmacologic treatment of alcoholic intoxication, withdrawal, and dependence: A critical review. J Stud Alcohol 48:356-370, 1987
2. Litten RZ, Allen JP: Pharmacotherapies for alcoholism: Promising agents and clinical issues. Alcohol Clin Exp Res 15:620-633, 1991
3. Sellers EM, Higgins GA, Tompkins DM, Romach MK, Tonnatto T: Opportunities for treatment of psychoactive substance abuse disorders with serotonergic medications. J Clin Psychiatry 52(Suppl.):49-54, 1991
4. Rezvani AH, Overstreet DH, Janowsky DS: Drug-induced reductions in ethanol intake in alcohol preferring and Fawn-Hooded rats. Alcohol (Suppl. 1):433-437, 1991
5. Rezvani AH, Grady DR: Suppression of alcohol consumption by fenfluramine in Fawn-Hooded rats with serotonin dysfunction. Pharmacol Biochem Behav 48:105-110, 1994
6. Meert TF: Effects of various serotonergic agents on alcohol intake and alcohol preference in Wistar rats selected at two different levels of alcohol preference. Alcohol 28:157-170, 1993
7. Sellers EM, Roach CA, Woodley DV, Sanchez-Craig M, Sykora K: Zimelidine-induced variations in alcohol intake by non-depressed heavy drinkers. Clin Pharmacol Ther 35:374-381, 1984
8. Naranjo CA, Sellers EM, Sullivan JT, Woodley DV, Kadlec K, Sykora K: The serotonin uptake inhibitor citalopram attenuates alcohol intake. Clin Pharmacol Ther 41:266-274, 1987
9. Naranjo CA, Poulos CX, Bremner KE, Lanctot KL: Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers. Clin Pharmacol Ther 51:729-739, 1992
10. Naranjo CA, Sullivan JT, Kadlec KE, Woodley-Remus DV, Kennedy G, Sellers EM: Differential effects of viqualine on alcohol intake and other consummatory behaviors. Clin Pharmacol Ther 46:301-309, 1989
11. Monti JM, Alterwain P: Ritanserin decreases alcohol intake in chronic alcoholics. Lancet 337:60, 1991
12. Sellers EM, Romach MK, Tonnatto T, Sobell LC, Somer GR, Sobell MB: Efficacy of ondansetron, a 5-HT3 antagonist, in alcoholism treatment. Biol Psychiatry 29:49-55, 1991
13. Naranjo CA, Kadlec KE, Sanhueza P, Woodley-Remus D, Sellers EM: Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers. Clin Pharmacol Ther 47:490-498, 1990
14. Gorelick DA, Paredes A: Effect of fluoxetine on alcohol consumption in male alcoholics. Alcohol Clin Exp Res 16:261-265, 1992
15. Cornelius JR, Salloum IM, Cornelius MD, Perel LM, Thase ME, Ehler JG, Mann JJ: Fluoxetine trial in suicidally depressed alcoholics. Psychopharmacol Bull 29:195-199, 1993
16. Gerra C, Caccavari R, Delsignore R, Bocchi R, Fertonani G, Passeri M: Effect of fluoxetine and Ca-acetyl-homotaurinate on alcohol intake in familial and non-familial alcoholic patients. Curr Ther Res 52:291-295, 1992
17. Kranzler HR, Burleson JA, Korner J, DelBoca FK, Bohn MJ, Brown J, Liebowitz N: Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. Am J Psychiatry 152:391-397, 1995
18. Spitzer RL, Williams JBW, Gibbon M, First MB: The Structured Clinical Interview for DSM-III-R (SCID). I. History, rationale, and description. Arch Gen Psychiatry 49:624-629, 1992
19. Selzer M: The Michigan Alcoholism Screening Test: The quest for a new diagnostic instrument. Am J Psychiatry 127:1653-1658, 1971
20. Feighner JP, Robins E, Woodruff RA, Winokur G, Munoz R: Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 26:57-63, 1972
21. Spitzer RL, Williams JBW, Gibbon M, First MB: The Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II, 9/1/89 version). New York, New York State Psychiatric Institute, 1989
22. Cloninger CR: A systematic method for clinical description and classification of personality variants. Arch Gen Psychiatry 44:573-588, 1987
23. Tiffany ST, Drobes DJ: The development and initial validation of a questionnaire on smoking urges. Br J Addict 86:1467-1476, 1991
24. Schenker S, Bergstrom RF, Wolen RL, Lemberger L: Fluoxetine disposition and elimination in cirrhosis. Clin Pharmacol Ther 44:353-359, 1988
25. Bergstrom RF, Beasley CM, Levy NB, Blumenfield M, Lemberger L: The effects of renal and hepatic disease on the pharmacokinetics, renal tolerance, and risk-benefit profile of fluoxetine. Int Clin Psychopharmacol 8:261-266, 1993
26. Lemberger L, Bergstrom RF, Wolen RL, Farid NA, Enas GG, Aronoff GR: Fluoxetine: Clinical pharmacology and physiologic disposition. J Clin Psychiatry 46:14-19, 1985
27. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP: Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876-880, 1992
28. Grabowski J, Rhoades H, Elk R, Schmitz J, Davis C, Creson D, Kirby K: Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: Two placebo-controlled double-blind trials. J Clin Psychopharmacol 15:163-174, 1995
29. Naranjo CA, Bremner KE, Lanctot KL: Effects of citalopram and a brief psycho-social intervention on alcohol intake, dependence and problems. Addiction 90:87-99, 1995
30. Balldin J, Berggren U, Engel J, Eriksson M, Hard E, Soderpalm B: Effect of citalopram on alcohol intake in heavy drinkers. Alcohol Clin Exp Res 18:1133-1136, 1994
31. Cornelius JR, Salloum IM, Cornelius MD, Perel JM, Ehler JG, Jarrett PJ, Levin RL, Black A, Mann JJ: Preliminary report: Double-blind placebo-controlled study of fluoxetine in depressed alcoholics. Psychopharmacol Bull 31:297-303, 1995
32. Penick EC, Powell BJ, Nickel EJ, Bingham SF, Riesenmy KR, Read MR, Campbell J: Comorbidity of lifetime psychiatric disorder among male alcoholic patients. Alcohol Clin Exp Res 18:1289-1293, 1994